The television broadcaster behind the cult cooking show Iron Chef has lost its opposition to an ‘Iron Chef’ trade mark application by an Aussie food delivery app developer, despite IP Australia finding the show had garnered a “moderate reputation” among Australian viewers.
Virgin Australia unsecured bondholders have launched an application with the Takeovers Panel in a bid to stop the sale of the embattled airline to Bain Capital, claiming certain elements of the administration process were “unacceptable”.
A public sector lawyer has won a bid to have the workplace umpire hear claims he was refused pay rises after engaging in allegedly inappropriate behaviour that included wearing Zara brand shoes and woollen jumpers in the winter months.
National delivery company Megasave Couriers and its sole director have been taken to court by the consumer watchdog, which alleges franchisees were duped into purchasing a franchise outlet by false promises of guaranteed minimum weekly payments and annual income.
Hall & Wilcox has lured an insolvency ace from McCullough Robertson to bolster its insolvency and commercial litigation team in Brisbane.
Maddens has once again been criticised for its non-compliant costs agreements, three months after receiving similar feedback from a Victoria Supreme Court judge overseeing the firm’s bushfire class actions.
Westpac has become the latest company to discover it shortchanged workers, announcing it will pay $8 million to around 8,000 current and former staff who were not paid long service leave entitlements.
A US-based aviation leasing company has launched proceedings against Virgin Australia and its administrators, seeking possession of aircraft engines and other parts in the first legal challenge to the conduct of the administration.
Law firms seeking to bring class actions on a contingency fee basis in the Victorian Supreme Court must seek court approval for the now-legal arrangement as early as possible in the proceeding, the court has said.
Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.